Medications

Trial results of new drug for generalized myasthenia gravis

Argenx, a Belgium pharmaceutical company, recently announced that The Lancet Neurology has published pivotal trial results from the Phase 3 ADAPT trial of efgartigimod, an FcRn antagonist, for the treatment of adults living ...

Vaccination

Biden announces Uber, Lyft rides amid July 4 vaccine push

President Joe Biden is highlighting new efforts to encourage Americans to get COVID-19 shots, including free rides to and from vaccination sites from ride-sharing companies Uber and Lyft, as the pace of shots nationally declines ...

Diseases, Conditions, Syndromes

5 strategies to prepare now for the next pandemic

While the world is still reeling from the COVID-19 pandemic, public health and emergency management experts are already preparing for the next one. After all, biologists are certain another dangerous new pathogen will emerge ...

Parkinson's & Movement disorders

Telehealth use up markedly among Parkinson patients

Parkinson disease (PD) symptoms and management practices were markedly affected by COVID-19, according to a study published online Jan. 21 in npj Parkinson's Disease.

Vaccination

Tdap or Td vaccine may be used for decennial Td booster doses

(HealthDay)—Either tetanus and diphtheria toxoids (Td) vaccine or tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine may be used for Td booster doses every 10 years or when indicated for tetanus ...

page 7 from 21